Həyat‑pro CEO‑su proqnozlaşdırır ki, Trampın FDA namizədi abort dərmanı risklərinə yenidən diqqət yetirə bilər
foxnews.com
25.08.2026 19:38
12 baxış
Trump's FDA nominee Heidi Overton could bring renewed scrutiny to mifepristone, says Americans United for Life CEO who calls her a "pro-life" pick.
Əlaqəli xəbərlər
Justice Dept. Charges Owner of Failed Surrogacy Firm With Fraud
nytimes.com · 26.08
Secret Service Officials Said to Be Put on Leave Amid Internal Inquiry
nytimes.com · 26.08
Cam Skattebo Starts Training Camp Scuffle With Giants Teammates: Report
newsweek.com · 26.08
Seahawks' Jaxon Smith-Njigba Just Got Some Brag-Worthy Recognition
newsweek.com · 26.08
Matthew Stafford Gets Major Props Heading Into 2026
newsweek.com · 26.08
Trump-Appointed Judge Sides With Texas Over Minnesota in ICE Agent Case
newsweek.com · 26.08